Quality of poultry litter submitted to different treatments in five consecutive flocks Qualidade da cama de frango submetida a diferentes tratamentos em cinco lotes consecutivos

It was evaluated the effects of poultry litter treatment on moisture content, pH, density and volatilized ammonia for five consecutive flocks of broiler chicken breeding. It was used 640 birds per flock as a complete randomized design with eight treatments and four replicates. The treatments were the following: 1 non-treated litter; 2 litter submitted to in-house composting; 3 litter treated with aluminum sulfate; 4 litter submitted to gypsum; 5 litter treated with quicklime; 6 litter treated with dolomitic limestone; 7 litter treated with zeolite and 8 litter treated with charcoal. Chopped elephant-grass hay was used as poultry litter in all flocks. Fermentation in the shed increased moisture content of the litters in the second and first flocks on 21 and 42 days of breeding, respectively. There was no difference on density among treatments. Aluminum sulfate reduced pH of the litters in all flocks at 21 days of breding. On 42 days of breeding, pH of the litters was reduced in the litters with aluminum sulfate and gypsum in the first, second and forth flocks. On 21 days, aluminum sulfate reduced the volatilized ammonia in the first, third and forth flocks, and on 42 days, there was a reduction of volatilized ammonia in the litters with aluminum sulfate in the forth flock. Aluminum sulfate can improve quality of poultry litter of chopped elephant-grass hay by reducing pH and ammonia volatilization.<br>Foram avaliados os efeitos do tratamento da cama de frango sobre o teor de umidade, o pH, a densidade e a amônia volatilizada durante cinco lotes consecutivos de criação de frangos de corte. Foram utilizadas 640 aves por lote em delineamento inteiramente casualizado com oito tratamentos e quatro repetições. Os tratamentos foram: 1 cama não-tratada; 2 cama submetida à compostagem dentro do galpão; 3 cama tratada com sulfato de alumínio; 4 cama tratada com gesso agrícola; 5 cama tratada com cal virgem; 6 cama tratada com calcário dolomítico; 7 cama tratada com zeolita; e 8 cama tratada com carvão vegetal. O feno de capim-elefante picado foi utilizado como cama de frango em todos os lotes. A fermentação no galpão aumentou o teor de umidade das camas no segundo e primeiro lotes aos 21 e 42 dias de criação, respectivamente. Não houve diferença na densidade entre os tratamentos. O sulfato de alumínio reduziu o pH das camas em todos os lotes aos 21 dias de criação. Aos 42 dias, o pH das camas foi reduzido nas camas contendo sulfato de alumínio e gesso agrícola no primeiro, segundo e quarto lotes. Aos 21 dias, o sulfato de alumínio reduziu a amônia volatilizada no primeiro, terceiro e quarto lotes e, aos 42 dias, houve redução da amônia volatilizada das camas contendo sulfato de alumínio no quarto lote. O sulfato de alumínio pode melhorar a qualidade da cama de frango de feno de capim-elefante picado, por reduzir o pH e a volatilização de amônia

Death in hospital following ICU discharge : insights from the LUNG SAFE study

Altres ajuts: Italian Ministry of University and Research (MIUR)-Department of Excellence project PREMIA (PREcision MedIcine Approach: bringing biomarker research to clinic); Science Foundation Ireland Future Research Leaders Award; European Society of Intensive Care Medicine (ESICM), Brussels; St Michael's Hospital, Toronto; University of Milan-Bicocca, Monza, Italy.Background: To determine the frequency of, and factors associated with, death in hospital following ICU discharge to the ward. Methods: The Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE study was an international, multicenter, prospective cohort study of patients with severe respiratory failure, conducted across 459 ICUs from 50 countries globally. This study aimed to understand the frequency and factors associated with death in hospital in patients who survived their ICU stay. We examined outcomes in the subpopulation discharged with no limitations of life sustaining treatments ('treatment limitations'), and the subpopulations with treatment limitations. Results: 2186 (94%) patients with no treatment limitations discharged from ICU survived, while 142 (6%) died in hospital. 118 (61%) of patients with treatment limitations survived while 77 (39%) patients died in hospital. Patients without treatment limitations that died in hospital after ICU discharge were older, more likely to have COPD, immunocompromise or chronic renal failure, less likely to have trauma as a risk factor for ARDS. Patients that died post ICU discharge were less likely to receive neuromuscular blockade, or to receive any adjunctive measure, and had a higher pre- ICU discharge non-pulmonary SOFA score. A similar pattern was seen in patients with treatment limitations that died in hospital following ICU discharge. Conclusions: A significant proportion of patients die in hospital following discharge from ICU, with higher mortality in patients with limitations of life-sustaining treatments in place. Non-survivors had higher systemic illness severity scores at ICU discharge than survivors. Trial Registration: ClinicalTrials.gov NCT02010073

Correction to: Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study

Correction to: Intensive Care Med (2016) 42:1865\u20131876 DOI 10.1007/s00134-016-4571-

Resolved versus confirmed ARDS after 24&#160;h: insights from the LUNG SAFE study

Purpose: To evaluate patients with resolved versus confirmed ARDS, identify subgroups with substantial mortality risk, and to determine the utility of day 2 ARDS reclassification. Methods: Our primary objective, in this secondary LUNG SAFE analysis, was to compare outcome in patients with resolved versus confirmed ARDS after 24\ua0h. Secondary objectives included identifying factors associated with ARDS persistence and mortality, and the utility of day 2 ARDS reclassification. Results: Of 2377 patients fulfilling the ARDS definition on the first day of ARDS (day 1) and receiving invasive mechanical ventilation, 503 (24%) no longer fulfilled the ARDS definition the next day, 52% of whom initially had moderate or severe ARDS. Higher tidal volume on day 1 of ARDS was associated with confirmed ARDS [OR 1.07 (CI 1.01\u20131.13), P = 0.035]. Hospital mortality was 38% overall, ranging from 31% in resolved ARDS to 41% in confirmed ARDS, and 57% in confirmed severe ARDS at day 2. In both\ua0resolved and confirmed\ua0ARDS, age, non-respiratory SOFA score, lower PEEP and P/F ratio, higher peak pressure and respiratory rate were each\ua0associated with mortality. In confirmed ARDS, pH and the presence of immunosuppression or neoplasm were also associated\ua0with mortality. The increase in area under the receiver operating curve for ARDS reclassification on day 2 was marginal. Conclusions: ARDS, whether resolved or confirmed at day 2, has a high mortality rate. ARDS reclassification at day 2 has limited predictive value for mortality. The substantial mortality risk in severe confirmed ARDS suggests that complex interventions might best be tested in this population. Trial Registration: ClinicalTrials.gov NCT02010073. \ua9 2018, Springer-Verlag GmbH Germany, part of Springer Nature and ESICM

Outcomes of Patients Presenting with Mild Acute Respiratory Distress Syndrome: Insights from the LUNG SAFE Study

WHAT WE ALREADY KNOW ABOUT THIS TOPIC: Hospital mortality in acute respiratory distress syndrome is approximately 40%, but mortality and trajectory in "mild" acute respiratory distress syndrome (classified only since 2012) are unknown, and many cases are not detected WHAT THIS ARTICLE TELLS US THAT IS NEW: Approximately 80% of cases of mild acute respiratory distress syndrome persist or worsen in the first week; in all cases, the mortality is substantial (30%) and is higher (37%) in those in whom the acute respiratory distress syndrome progresses BACKGROUND:: Patients with initial mild acute respiratory distress syndrome are often underrecognized and mistakenly considered to have low disease severity and favorable outcomes. They represent a relatively poorly characterized population that was only classified as having acute respiratory distress syndrome in the most recent definition. Our primary objective was to describe the natural course and the factors associated with worsening and mortality in this population. METHODS: This study analyzed patients from the international prospective Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE) who had initial mild acute respiratory distress syndrome in the first day of inclusion. This study defined three groups based on the evolution of severity in the first week: "worsening" if moderate or severe acute respiratory distress syndrome criteria were met, "persisting" if mild acute respiratory distress syndrome criteria were the most severe category, and "improving" if patients did not fulfill acute respiratory distress syndrome criteria any more from day 2. RESULTS: Among 580 patients with initial mild acute respiratory distress syndrome, 18% (103 of 580) continuously improved, 36% (210 of 580) had persisting mild acute respiratory distress syndrome, and 46% (267 of 580) worsened in the first week after acute respiratory distress syndrome onset. Global in-hospital mortality was 30% (172 of 576; specifically 10% [10 of 101], 30% [63 of 210], and 37% [99 of 265] for patients with improving, persisting, and worsening acute respiratory distress syndrome, respectively), and the median (interquartile range) duration of mechanical ventilation was 7 (4, 14) days (specifically 3 [2, 5], 7 [4, 14], and 11 [6, 18] days for patients with improving, persisting, and worsening acute respiratory distress syndrome, respectively). Admissions for trauma or pneumonia, higher nonpulmonary sequential organ failure assessment score, lower partial pressure of alveolar oxygen/fraction of inspired oxygen, and higher peak inspiratory pressure were independently associated with worsening. CONCLUSIONS: Most patients with initial mild acute respiratory distress syndrome continue to fulfill acute respiratory distress syndrome criteria in the first week, and nearly half worsen in severity. Their mortality is high, particularly in patients with worsening acute respiratory distress syndrome, emphasizing the need for close attention to this patient population